Nano-X Imaging Ltd. (NASDAQ: NNOX) announced that its U.S. subsidiary has signed a distribution agreement with Radiology Oncology Systems to distribute Nanox.ARC systems across the United States.

Under the agreement, Radiology Oncology Systems will support the commercial rollout of the Nanox.ARC, an FDA-cleared multisource digital tomosynthesis system. The company describes the system as enabling 3D imaging at lower cost and reduced radiation dose compared to traditional CT scans.

Radiology Oncology Systems provides diagnostic imaging and oncology equipment to hospitals and clinics nationwide. The partnership aims to expand access to imaging solutions in U.S. clinical settings, including oncology-related care environments.

"We continue to systematically expand our U.S. commercial footprint through targeted distribution agreements," said Erez Meltzer, Chief Executive Officer and Acting Chairman of Nanox. "Radiology Oncology Systems adds another experienced partner to our growing U.S. network."

John Vano, President and Chief Executive Officer of Radiology Oncology Systems, said the company believes the Nanox.ARC aligns with its focus on delivering accessible imaging solutions to U.S. healthcare providers.

The agreement represents part of Nanox's strategy to build a distribution network across the United States. Radiology Oncology Systems has operated for over 25 years, providing reconditioned radiation therapy and diagnostic imaging equipment including linear accelerators, CT scanners, and MRI systems.

The information is based on a company press release statement.